全文获取类型
收费全文 | 353681篇 |
免费 | 23762篇 |
国内免费 | 6643篇 |
专业分类
耳鼻咽喉 | 4119篇 |
儿科学 | 9778篇 |
妇产科学 | 6740篇 |
基础医学 | 27491篇 |
口腔科学 | 7934篇 |
临床医学 | 40216篇 |
内科学 | 42567篇 |
皮肤病学 | 4704篇 |
神经病学 | 19969篇 |
特种医学 | 8345篇 |
外国民族医学 | 31篇 |
外科学 | 37036篇 |
综合类 | 52640篇 |
一般理论 | 32篇 |
预防医学 | 37603篇 |
眼科学 | 5188篇 |
药学 | 32888篇 |
696篇 | |
中国医学 | 32684篇 |
肿瘤学 | 13425篇 |
出版年
2023年 | 5538篇 |
2022年 | 8364篇 |
2021年 | 12813篇 |
2020年 | 14374篇 |
2019年 | 23435篇 |
2018年 | 15728篇 |
2017年 | 13161篇 |
2016年 | 10272篇 |
2015年 | 9679篇 |
2014年 | 20769篇 |
2013年 | 22017篇 |
2012年 | 19025篇 |
2011年 | 20682篇 |
2010年 | 16476篇 |
2009年 | 15188篇 |
2008年 | 14705篇 |
2007年 | 15225篇 |
2006年 | 13282篇 |
2005年 | 11476篇 |
2004年 | 9327篇 |
2003年 | 8159篇 |
2002年 | 6384篇 |
2001年 | 5733篇 |
2000年 | 4746篇 |
1999年 | 4022篇 |
1998年 | 3110篇 |
1997年 | 2973篇 |
1996年 | 2565篇 |
1995年 | 2641篇 |
1994年 | 2541篇 |
1993年 | 2027篇 |
1992年 | 2060篇 |
1991年 | 1776篇 |
1990年 | 1586篇 |
1989年 | 1407篇 |
1988年 | 1341篇 |
1987年 | 1145篇 |
1985年 | 3807篇 |
1984年 | 4810篇 |
1983年 | 3345篇 |
1982年 | 3808篇 |
1981年 | 3559篇 |
1980年 | 3166篇 |
1979年 | 2910篇 |
1978年 | 2536篇 |
1977年 | 1909篇 |
1976年 | 2152篇 |
1975年 | 1635篇 |
1974年 | 1424篇 |
1973年 | 1276篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Mahmut Gümüş MD Chieh-I Chen MPH Cristina Ivanescu PhD Saadettin Kilickap MD Igor Bondarenko MD Mustafa Özgüroğlu MD Miranda Gogishvili MD Haci M. Turk MD Irfan Cicin MD James Harnett PharmD Vera Mastey MS Ulrike Naumann MS Matthew Reaney MS Gerasimos Konidaris MS Medha Sasane PhD Keri J. S. Brady PhD Siyu Li PhD Giuseppe Gullo MD Petra Rietschel MD Ahmet Sezer MD 《Cancer》2023,129(1):118-129
4.
5.
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial
Areej El-Jawahri MD Marlise R. Luskin MD Joseph A. Greer PhD Lara Traeger PhD Mitchell Lavoie BS Dagny Marie Vaughn BS Stephanie Andrews BS Daniel Yang BS Kofi Y. Boateng BS Richard A. Newcomb MD Nneka N. Ufere MD Amir T. Fathi MD Gabriela Hobbs MD Andrew Brunner MD Gregory A. Abel MD Richard M. Stone MD Daniel J. DeAngelo MD PhD Martha Wadleigh MD Jennifer S. Temel MD 《Cancer》2023,129(7):1075-1084
6.
7.
8.
Dikshat Gopal Gupta PhD Neelam Varma MD Praveen Sharma MD Mihai I. Truica MD PhD Sarki A. Abdulkadir MD PhD Parmod Singh PhD Man Updesh Singh Sachdeva MD Shano Naseem MD Mohammad Rizwan Siddiqui PhD Parveen Bose MSc Jogeshwar Binota MSc Pankaj Malhotra MD Alka Khadwal MD Amita Trehan Subhash Varma MD 《Cancer》2023,129(21):3390-3404
9.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
10.
Nicolas Penel Sylvie Bonvalot Marie-Cécile Le Deley Antoine Italiano Camille Tlemsani Diane Pannier Clémence Leguillette Jean-Emmanuel Kurtz Maud Toulmonde Julien Thery Daniel Orbach Pascale Dubray-Longeras Benjamin Verret François Bertucci Cécile Guillemet Lucie Laroche Armelle Dufresne Jean-Yves Blay Axel Le Cesne 《International journal of cancer. Journal international du cancer》2023,153(2):407-416
The aim of this study is to evaluate the prevalence, determinants and prognostic value of pain at diagnosis in patients with desmoid-type fibromatosis (DF). We selected patients from the ALTITUDES cohort (NCT02867033), managed by surgery, active surveillance or systemic treatments, with pain assessment at diagnosis. Patients were invited to fill QLQ-C30 questionnaire and Hospital Anxiety Depression Scale. Determinants were identified using logistic models. Prognostic value on event-free survival (EFS) was evaluated using the Cox model. Overall, 382 patients were included in the current study (median age: 40.2 years; 117 men). The prevalence of pain was 36%, without significant difference according to first-line treatment (P = .18). In the multivariate analysis, pain was significantly associated with tumor size >50 mm (P = .013) and tumor site (P < .001); pain was more frequent in the neck and shoulder locations (odds ratio: 3.05 [1.27-7.29]). Pain at baseline was significantly associated with poor quality of life (P < .001), depression (P = .02), lower performance status (P = .03) and functional impairment (P = .001); we also observed a nonsignificant association with anxiety (P = .10). In the univariate analysis, baseline pain was associated with poor EFS; the 3-year EFS was 54% in patients with pain compared to 72% in those without pain. After adjustment for sex, age, size and line of treatment, pain was still associated with poor EFS (hazard ratio: 1.82 [1.23-2.68], P = .003). One third of recently diagnosed patients with DF experienced pain, especially those with larger tumors and neck/shoulder locations. Pain was associated with unfavorable EFS after adjustment for the confounders. 相似文献